How are skeletal tissues derived from skeletal stem cells? Here, we map bone, cartilage, and stromal development from a population of highly pure, postnatal skeletal stem cells (mouse skeletal stem cells, mSSCs) to their downstream progenitors of bone, cartilage, and stromal tissue. We then investigated the transcriptome of the stem/progenitor cells for unique gene-expression patterns that would indicate potential regulators of mSSC lineage commitment. We demonstrate that mSSC niche factors can be potent inducers of osteogenesis, and several specific combinations of recombinant mSSC niche factors can activate mSSC genetic programs in situ, even in nonskeletal tissues, resulting in de novo formation of cartilage or bone and bone marrow stroma. Inducing mSSC formation with soluble factors and subsequently regulating the mSSC niche to specify its differentiation toward bone, cartilage, or stromal cells could represent a paradigm shift in the therapeutic regeneration of skeletal tissues.
INTRODUCTION
Stem cell regulation in the skeletal system, as compared to the hematopoietic system, remains relatively unexplored. Pioneering studies by Friedenstein et al. established the presence of colony-forming skeletogenic cells, but only recently have efforts begun to identify and isolate bone, cartilage, and stromal progenitors for rigorous functional characterization (Bianco, 2011; Chan et al., 2013; Friedenstein et al., 1987; Mé ndez-Ferrer et al., 2010; Morrison et al., 2006; Park et al., 2012) . In addition, the bone marrow is a favored site of prostate and breast cancer metastasis, and the characteristics of the bone stroma supporting metastatic stem cell niches are largely uncharted. Another important challenge in tissue regeneration is the limited capacity to (re)generate cartilage, which is deficient in many diseases (e.g., osteoarthritis, connective tissue disorders) (Burr, 2004; Kilic et al., 2014) .
We hypothesized that the skeletal system follows a program similar to that of hematopoiesis, with a multipotent stem cell generating various lineages in a niche that regulates differentiation. Thus we sought to (1) identify a multipotent skeletal stem cell and map its relationship to its lineage-committed progeny and (2) identify cells and factors in the skeletal stem cell niche that regulate its activity.
RESULTS

Identification of the Skeletal Stem Cell, Its Progeny, and Their Lineage Relationships
Bone and Cartilage Are Derived from Clonal, Lineage-Restricted Progenitors We used a ''Rainbow mouse'' (Ueno and Weissman, 2006) model to evaluate clonal-lineage relationships in vivo to determine whether mesenchymal tissues in bone-including stroma, fat, bone, cartilage, and muscle-share a common progenitor (Rinkevich et al., 2011 ) (see Experimental Procedures). To visualize clonal patterns within all tissues, we crossed Rainbow mice with mice harboring a tamoxifen (TMX)-inducible ubiquitously expressed Cre under the actin promoter (Actin-Cre-ERT) (Figure 1C) . Six weeks after this recombinase activation, clonal regions could be detected as uniformly labeled areas of a distinct color (Figures S1A and S1B) . Using this system, we observe clonal regions in the bone, particularly at the growth plate, that encompass bone, cartilage, and stromal tissue but not hematopoietic, adipose, or muscle tissue at all time points studied (Figures 1A, and S1D) . These data indicate that bone, cartilage, and stromal tissue are clonally derived in vivo from lineage-restricted stem and progenitor cells that do not also give rise to muscle and fat, at least at the time points examined ( Figure S1 ).
Purified Cartilage, Bone, and Stromal Progenitor Cells Are Heterogeneous and Lineage Restricted As we had observed a high frequency of clonal regions in the growth plate during our Rainbow clonal analysis, we isolated cells from the femoral growth plates by enzymatic and mechanical dissociation and analyzed them by fluorescence-activated cell sorting (FACS) for differential expression of CD45, Ter-119, Tie2, and AlphaV integrin. These surface markers correspond to those present on hematopoietic (CD45, Ter-119), vascular and hematopoietic (Tie2), and osteoblastic (AlphaV integrin) cells. We found that the growth plate had a high frequency of cells that were CD45 ] showing differential expression of CD105, Thy, 6C3, and CD200, we fractionated this population into eight subpopulations (Figures 1B and 1E) (Seita et al., 2012) .
To evaluate the intrinsic ability of the eight subpopulations to give rise to skeletal tissue, we isolated cells of each subpopulation from the long bones, ribs, and sternum of GFP + mice (Figure 1E) and transplanted them beneath the renal capsules of immunodeficient mice ( Figure 1H ). Four weeks after transplantation, we explanted the GFP-labeled kidney grafts and processed the tissues for histological analysis to determine developmental outcome ( Figure 1F ). Based on the analyses described above, we defined a lineage tree of skeletal stem/progenitor cells ( Figure 2G ). The mSSC initiates skeletogenesis by producing a hierarchy of increasingly fatelimited progenitors. The multipotent and self-renewing mSSC first gives rise to multipotent progenitors, pre-BCSPs and BCSPs. These cells then produce the following oligolineage progenitors: pro-chondrogenic progenitors (PCPs) Figures 3D and 3E ).
To interpret the gene-expression profiles of these cells, we used the Gene Expression Commons (Seita et al., 2012) , a platform that normalizes microarray data against a large collection of publicly available microarray data from the National Center for Biotechnology Information Gene Expression Omnibus. From this analysis, it is apparent that mSSC and its progeny differentially express receptors involved in transforming growth factor, TGF (specifically bone morphogenetic protein [BMP] ) and Wnt signaling pathways, and cognate morphogens of these pathways, including BMP2, and Wnt3a (Figures 3D and 3E) . These results suggest that paracrine and/or autocrine signaling among mSSCs and their progeny may positively regulate their own expansion ( Figure 3F ). Furthermore, single cell RNA sequencing revealed coexpression of BMP2 and its receptor (BMPR1a) in 28% of mSSCs (Figures 3A-3C and S5), supporting potential for autocrine and/or paracrine signaling in the mSSCs.
In support of transcriptional data, the addition of exogenous recombinant BMP2 to culture media rapidly induced expansion of isolated mSSC, whereas supplementation of media with either exogenous recombinant TGF-b or tumor necrosis factor alpha (TNF-a) did not ( Figures 3G and 3H ). In addition, proliferation of mSSC in vitro was markedly inhibited by addition of recombinant gremlin 2 (an antagonist of BMP2 signaling) protein to culture media, in contrast to control. Progeny of the mSSCs express antagonists of the BMP2 signaling pathway, such as Gremlin 2 and Noggin ( Figure 3I ), suggesting the presence of a potential negative feedback mechanism to control mSSC proliferation by more differentiated progeny. Specifically, Thy expresses Gremlin 2, and both Thy and BLSP express Noggin. This is consistent with Thy and BLSP subpopulations acting in a negative feedback loop to inhibit BMP2-induced proliferation of the mSSC, further supporting a regulatory role for paracrine signaling among mSSCs and their progeny. Shifting Fates: Cartilage to Bone Our next step was to comprehend signaling pathways that could play a role in directing the differentiation of skeletal stem/progenitor cells. Specifically, we wished to direct osteogenesis to chondrogenesis, as this is directly related to a large unmet clinical need for cartilage (Bhumiratana et al., 2014; Jo et al., 2014; Makris et al., 2014; Mollon et al., 2013) . We asked whether mSSC-derived stroma could influence fate commitment of skeletal progenitor cells ( Figure 2G ). We observed that the skeletal subsets with the immunophenotype [CD45 (D) Gene-expression levels of Wnt-associated genes in skeletal populations as determined using the Gene Expression Commons analysis platform. The range of transcriptional expression is illustrated by a color change as depicted on the extreme right of the figure (i.e., dark purple correlates to high expression, whereas dark blue correlates to low expression). Heatmap shows high expression of both Wnt ligands (Wnt3a, Wnt4, Wnt5a) and receptors (Fzd5-9), demonstrating that Wnt signaling may be actively involved in skeletal progenitor function. Fzd = frizzled receptor. These data were compiled in triplicate, with 10,000 cells of each subset analyzed in each sample. from RFP + mice are directed primarily toward cartilage formation when transplanted in isolation beneath the renal capsule of nonfluorescent mice; thus, we designated this cell the PCP (Figures 4A and 4B) . However, when RFP-labeled PCPs ( Figure 2G ) are cotransplanted with GFP-labeled BCSPs, they differentiate into bone but not cartilage ( Figure 4C ). Shifting Fates: Bone to Cartilage Having observed that signaling from cotransplanted BCSP could divert cartilage-fated cells toward bone formation, we next sought to identify factors that could, conversely, selectively promote mSSCs to cartilage rather than bone fates. Emerging evidence indicates that increased VEGF expression can spur resting chondrocytes to re-enter a hypertrophic state and resume endochondral ossification (Saito et al., 2010; Street et al., 2002) . Thus, we aimed to determine whether inhibition of VEGF signaling could promote chondrogenic differentiation of mSSCs by blocking VEGF-dependent ossification ( Figure 5A ). We administered adenoviral vectors encoding a soluble ligandbinding ectodomain (ECD) of the VEGFR1 receptor (Ad sVEGFR1) intravenously, leading to potent systemic VEGF antagonism (Wei et al., 2013) . Adenovirus encoding a control immunoglobulin IgG2a Fc domain served as control treatment.
One day later, we transplanted either intact embryonic day (E) 14.5 pre-osteogenic fetal femora or freshly sorted mSSCs under the renal capsules of these mice and then explanted the tissue 3 weeks later ( Figure 5A ). The grafts from the Ad sVEGFR1-treated mice contained predominantly cartilaginous tissue (Figure 5B, right) . In contrast, the grafts from the control Ad Fc animals evidenced endochondral ossification and formation of a marrow cavity surrounded by cortical bone ( Figure 5B , left). These results suggest that VEGF blockade may promote chondrogenesis at the expense of osteogenesis ( Figure 5C ).
BMP Pathway Manipulation Can Induce De Novo Formation of the mSSC in Extraskeletal Locations
We next investigated whether other tissue types contain cells that are osteo-inducible or harbor dormant mSSCs that can be activated to undergo osteogenesis. As we observed that BMP2 can expand mSSC in vitro ( Figures 3G and 3H ), we tested BMP2 as an agent that may induce such osteogenesis. We placed collagen sponges containing recombinant BMP2 into subcutaneous extraskeletal sites. Harvest of the collagen sponges 4 weeks after placement revealed abundant osseous derived from the mSSCs (indicated by arrowhead in control, 50 pg/ml, 500 pg/ml, 5 ng/ml and by a broken line in 50 ng/ml and 500 ng/ml) (right). Scale bar: 500 mm, n = 3. osteoids replete with marrow ( Figures 6A-6C) . Furthermore, FACS analysis of cells within the marrow of the induced osteoids revealed that hematopoietic stem cell (HSC) engraftment also occurs in the osteoids ( Figure 6B) . By FACS analysis, we determined that mSSCs are normally not detectable or are exceedingly rare in subcutaneous adipose tissue ( Figure 6C , right panel). In contrast, mSSCs are plentiful in BMP2-induced osteoids 10 days after implantation, whereas ossification is still proceeding ( Figure 6C , left panel).
To determine whether BMP2 induced skeletal transformation of in situ cells or migration of circulating skeletal progenitors recruited from bone tissue, we used a parabiont model ( Figure 6D ). We surgically fused actin-GFP transgenic mice to non-GFP congenic mice such that they established a shared circulatory system (Conboy et al., 2013) . Two weeks after parabiosis, after confirmation of chimerism, we implanted collagen sponges containing recombinant BMP2 into the inguinal fat pad of the non-GFP parabiont. Ten days after implantation, we explanted the sponge and surrounding tissue and performed mechanical and chemical dissociation to isolate the constituent cells. We assayed the contribution of the GFP-labeled cells to ectopic bone formation in the non-GFP mouse by FACs analysis to determine whether circulating cells contributed to ectopic bone development. The tissue of the explants contained abundant GFP-labeled cells at harvest, but GFP-labeled cells in the graft were solely CD45 + hematopoietic cells ( Figure 6D , left panel, top and bottom) and not skeletal progenitors ( Figure 6D , FACS plots, mSSC cell population shown on far right). The skeletal progenitor population present in the explanted tissue was entirely GFP negative, suggesting that circulating cells did not contribute to BMP2-induced ectopic bone. These data indicate that BMP2-induced osteogenesis involves local cell response that is sufficient to induce mSSC formation in the subcutaneous fat pads, leading to formation of ectopic bone that can support hematopoiesis. We next wished to determine which cell types could undergo BMP2-mediated reprogramming to mSSC in these extraskeletal sites. We, therefore, conducted FACS analysis of suspended cells isolated from the kidney and the subcutaneous adipose tissue and looked for markers that could distinguish cell types common to both of these extraskeletal organs. We found that both kidney and adipose tissue contain high numbers of Tie2 (Arai et al., 2004; De Palma et al., 2005; Heldin and Westermark, 1999) . Using a specific Tie2Cre 3 MTMG reporter mouse, which genetically labels cells that expressed Tie2 with GFP and other cells with RFP, we again inserted collagen sponges containing (A) Scheme of experiment: mSSCs were isolated from P3 mice as described previously. Either intact pre-osteogenic femora isolated from E14.5 mice or 20,000 mSSCs were then transplanted beneath the kidney capsules of recipient mice with/without systemic inhibition of VEGF signaling. For inhibition of VEGF signaling, adenoviral vectors encoding soluble VEGFR1 ectodomain (Ad sVEGFR1) were delivered intravenously to the recipient mice 24 hr prior to cell transplantation, leading to systemic release of this potent antagonist of VEGF signaling. Ad Fc encoding an immunoglobulin Fc fragment was served as a negative control. Grafts were explanted 3 weeks later. recombinant BMP2 into the inguinal fat pad and harvested the implanted tissue 1 month later ( Figure 6E ). FACS analysis revealed that BMP2-derived ossicles clearly incorporated GFP-positive Tie2-derived osteocytes with visible canaliculi (Figure 6F , high-magnification inset) and Tie2-negative RFP-labeled osteocytes ( Figure 6F ), suggesting that both Tie2-positive and Tie2-negative lineages underwent BMP2-induced skeletal reprogramming. These data suggest that a variety of cell types could potentially be induced by BMP2 to initiate formation of mSSC.
Codelivery of BMP2 and VEGF Inhibitor Is Sufficient to Induce De Novo Formation of Cartilage in Adipose Tissue
Although bone itself possesses regenerative ability, the capacity for regeneration in other skeletal tissue (e.g., cartilage) is very low. As BMP2 induction could stimulate mSSC expansion and formation ( Figures 3G, 3H , and 6C), we speculated that the mSSC-inducing capacity of BMP2 could be coupled with VEGF blockade to direct de novo cartilage formation. To test this possibility, we implanted BMP2-treated collagen sponges into the adipose tissue of mice that had either been treated 24 hr earlier with intravenous Ad sVEGFR1 as in Figure 5 or included soluble VEGFR1 ECD (50 mg) directly in the collagen sponge ( Figure 7A ). One month later, the tissues were explanted. BMP2 alone generated bone tissue with a marrow cavity (Figure 7B, left panel) . However, BMP2 with either systemic or local VEGF inhibition resulted in predominant cartilage formation (Figure 7B, right panel) . The induced cartilage contained a similar frequency of PCPs to that seen in natural cartilage ( Figure 7C ). As native adipose tissue normally does not undergo chondrogenesis, the induced cartilage likely derives from BMP2-induced mSSCs that were shifted toward cartilage fate by the action of VEGF blockade.
Translational Implications of Skeletal Stem Cell Biology
We next investigated the role of mSSCs in skeletal repair. Highlighting their potential regenerative capabilities, we find that the mSSC number is significantly higher in the callus of a fractured femur than in the uninjured femur ( Figures S6A and S6B) . Interestingly, mSSCs isolated from a fracture callus also demonstrate enhanced osteogenic capacity (in comparison to uninjured) in vitro ( Figure S6C , left panel) and in vivo ( Figure S6C , right panel). As it is well known that irradiation results in osteopenia and reduced fracture healing (Mitchell and Logan, 1998) , we asked whether the skeletal response to irradiation is linked to depletion of mSSC activity. When mice were irradiated 12 hr prior to fracture induction, we noted a significant reduction in mSSC expansion at 1 week following fracture in comparison to nonirradiated femora 1 week post-fracture ( Figure S6D ), echoing previous observations (Galloway et al., 2009 ).
DISCUSSION
Identifying Postnatal Skeletal Stem/Progenitor Cells and Defining the Lineage Tree
The mSSC lineage map we present consists of eight different cellular subpopulations with distinct skeletogenic properties and encompasses subpopulations that have characteristics of described skeletogenic cell types identified by lineage tracing (Bianco, 2014 , Mé ndez-Ferrer et al., 2010 Park et al., 2012; Zhou et al., 2014) . For example, the Thy subtype selectively expresses high levels of CXCL12, leptin receptor, and nestin, which are characteristics of CXCL12-abundant reticular cells, leptin receptor-expressing cells (LepR + ), and Nestin-expressing mesenchymal stem cells, respectively. We also find that both Nestin-cre-and MX1-cre-labeled populations overlap with the mSSC population ( Figure S3 ) .
Signals Controlling mSSC and Progenitor Activity Mechanistically, mSSC expansion and self-renewal must be tightly controlled, evidenced by the expression of numerous cognate receptors to signaling molecules belonging to most of the known signaling pathways, including Hedgehog, BMP, FGF, and Notch. Both BMP2 and 4 are expressed by mSSCs and most mSSC-derived subsets, where they likely mediate survival and expansion via both autocrine and paracrine loops. Conversely, downstream progeny of mSSCs, such as Thy and BLSP populations, express noggin and/or gremlin 2, which antagonize BMP signaling. This suggests that mSSCs and some of their progeny form a portion of their own niche, maintaining critical levels of prosurvival factors such as BMP2 but also controlling skeletal growth by antagonizing BMP signaling. In addition, mSSCs are dramatically amplified in fracture callus, implying that extrinsic signals generated in the regenerative environment could locally activate these cells ( Figure S6 ).
Directing Skeletal Progenitor Fate Determination from Bone to Cartilage
Antagonistic signaling between mSSC-derived skeletal subsets also appears to be a key mechanism in skeletal subset lineage commitment, particularly to either a bone or cartilage fate. When we antagonized VEGF signaling in early skeletal progenitors, bone fates were inhibited in favor of cartilage fates. These results echo previous reports, which suggest that VEGF acts as an essential chondrogenic regulator (Carlevaro et al., 2000; Gerber et al., 1999; Harper and Klagsbrun, 1999) .
Directing Skeletal Progenitor Fate Determination from Cartilage to Bone
Paracrine signaling among skeletal subsets may also participate in determining bone versus cartilage formation, specifically in favoring bone. Altered signaling in a particular subpopulation can direct the skeletal fate of other subpopulations in the microenvironment. It is possible that pathological conditions involving calcification of cartilaginous tissues, such as osteoarthritis, could stem from defects in the mSSC niche, leading to aberrant signaling that promotes osteogenesis.
Hematopoietic and Skeletal Stem Cell Homeostasis May Be Closely Related
At a transcriptional level, mSSC-generated progeny express numerous cytokines necessary for HSC maintenance and hematopoiesis, including Kit ligand and stromal-derived factor ( Figure S2C ). We also find evidence that stem and progenitor cells of the hematopoietic system may reciprocally regulate skeletal progenitors ( Figures S2A, S2B , and S2D). We conducted gene-expression analysis of multiple hematopoietic stem and progenitor subsets and found that hematopoietic progenitors express myriad factors associated with skeletogenesis, including BMP2, BMP7, and Wnt3a. As previously shown, the cognate receptors of these factors are highly expressed by mSSCs and their progeny ( Figures 3D and 3E) . Intriguingly, although mSSC-generated progeny, such as Thy and BLSP, selectively express receptors to circulating systemic hormones, such as leptin and thyroid-stimulating hormone, these receptors are not highly expressed in HSCs or hematopoietic subsets (Figure S2D ; data not shown; Seita et al., 2012) , thus, suggesting that mSSC-derived stromal cells may link systemic endocrine regulation to both skeletal and hematopoietic systems.
Altering Extraskeletal Niche Signaling to Induce Osteogenesis and Chondrogenesis
Modulating niche signaling can stimulate tissue growth by inducing proliferation of stem cells, as we have observed with skeletal stem cells and as described in the hematopoietic system (Calvi et al., 2003) . Niche interactions may also play significant roles in maintaining lineage commitment, for instance, high levels of BMP2 signaling can dominate local adipose signaling and re-specify resident Tie2 + and Tie2 À subsets to undergo osteogenesis. Niche interactions can also determine the fate of the mSSC. By implanting BMP2-treated collagen sponges in concert with systemic or local application of soluble VEGF receptor, we demonstrate that cartilage can be induced to form entirely by manipulation of local signaling pathways in extraskeletal tissue.
Conclusion
Inducing mSSC formation with soluble factors and subsequently regulating the mSSC niche to specify its differentiation toward bone, cartilage, or stromal cells could represent a paradigm shift in the therapeutic regeneration of skeletal tissues. This therapeutic modality could also extend to the codependent hematopoietic system even when resident levels of endogenous mSSCs have been depleted by disease or aging. The challenge now is to understand how intrinsic and extrinsic signals guide mSSCs to regulate skeletal shape and patterning at the single-cell level.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are described in the Extended Experimental Procedures.
Mice C57BL6, Rag-2/gamma(c)KO, C57BL/6-Tg(CAG-EGFP)1Osb/J, Mx1Cre, and mTmG were bred in our laboratory. Rosa-Tomato Red RFP and Tie2Cre mice were obtained from Jackson. ''Rainbow'' mice were bred with mice harboring a TMX-inducible ubiquitously expressed Cre under the promoter of the actin gene. Mice were bred at our animal facility according to NIH guidelines. Protocols were approved by the institutional review board.
Isolation and Transplantation of Adult and Fetal Skeletal Progenitors
Skeletal tissues were dissected from postnatal day (P) 3 GFP-labeled mice and dissociated by mechanical and enzymatic dissociation. Total dissociated cells were stained with fluorochrome-conjugated antibodies for fractionation by FACS. Sorted and unsorted skeletal progenitors were then injected under the renal capsule of immunodeficient mice.
Transcriptional Expression Profiling
Microarray analyses was performed on mSSC/pre-BCSPs, BCSPs, Thy + , 6C3 + , HEC, and BLSPs. RNA was isolated, twice amplified, streptavidinlabeled, fragmented, and hybridized to Affymetrix 430-2.0 arrays. Raw microarray data were submitted to Gene Expression Commons (http://gexc. stanford.edu). Heatmaps representing fold change of gene expression were generated in Gene Expression Commons.
Histological Analysis of Endochondral Ossification
Representative sections were stained with H&E, Movat's modified pentachrome, or alizarin red stains depending on requirement.
Immunofluorescence Briefly, specimens were treated with a blocking reagent, then probed with monoclonal antibody at 4 C overnight. Specimens were washed, probed with alexa-dye-conjugated antibodies, washed, and imaged with an inverted microscope.
Cell Culture
Skeletal progenitors were cultured in MEMa medium with 10% FCS, 1% penicillin-streptomycin under low O 2 (2% atmospheric oxygen, 7.5%CO 2 ) conditions. For mSSC colony-forming assays, single cells were sorted into each well of a 96-well plate and cultured for 2 weeks.
Parabiosis Age-and sex-matched congenic GFP and non-GFP mice were sutured together along the dorsal-dorsal and ventral-ventral folds of the skin flaps. Two weeks later, blood chimerism was assessed by FACS.
In Vivo Osteo-induction with BMP2 rhBMP2 was resuspended in sterile filtered buffer and applied to a collagen sponge. Sponge was lyophilized and transplanted subcutaneously into anesthetized mice.
Inhibition of VEGF Signaling
To study systemic inhibition of VEGF signaling, 10 9 pfu units of adenoviral vectors encoding the soluble murine VEGFR1 ectodomain (Ad sVEGFR1) was injected intravenously to the designated recipient mice 24 hr prior to transplantation, leading to hepatic infection and secretion of this potent antagonist of VEGF signaling into the circulation. For negative control, adenovirus encoding a murine IgG2a Fc immunoglobulin fragment was used (Ad Fc). These reagents are described elsewhere (Wei et al., 2013) . Local VEGF inhibition: 50 mg of soluble VEGFR1 was lyophilized together with recombinant BMP2 in a collagen sponge, which was then inserted into subcutaneous fat.
Single-Cell RNA Sequencing
This was performed as previously described (Treutlein et al., 2014) .
Mouse Femoral Fracture ± Hindlimb Irradiation An incision was made from the groin crease to the knee of the right femur. A medullary rod was placed via the intercondylar fossa. A bicortical transverse mid-diaphyseal fracture was created, and the skin incision closed with nylon sutures, and the mice received post-operative analgesia. The callus was harvested, and constituent cells isolated by mechanical and enzymatic dissociation and subsequent FACS fractionation. C57BL6 hindlimbs received a single dose of 800 rads (8Gy) to bilateral hind limbs. Surgical placement of fracture was performed 12 hr post-irradiation.
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